Patient Care Gene Study Points Researchers toward New Pathway for Leukemia By Lydia Fernandez May. 18, 2017 Leukemia is one of the hardest cancers to treat, but scientists have discovered a new, targetable pathway in one of the worst subtypes of the disease.
Research Wilmot Discovery Improves Use of Umbilical Cord Blood as Cancer Therapy By Leslie Orr Jan. 3, 2017 A clinician/scientist, who studies ways to make cord-blood transplants for leukemia and lymphoma patients safer and more effective, recently reported a new finding in the journal, Blood. An ...
Research As Leukemia Evolves, Stem Cells Hold Keys to Newer Therapies By Leslie Orr Aug. 29, 2016 A recent study by University of Rochester Medical Center researchers proves why leukemia is so difficult to treat and suggests that the current approach to drug development should be adjusted to ...
Patient Care Wilmot Cancer Institute celebrates 3,000th blood and marrow transplant By Lydia Fernandez Aug. 27, 2016 The Blood and Marrow Transplant (BMT) Program at UR Medicine’s Wilmot Cancer Institute recently performed its 3,000th transplant. The program, which opened in 1989, treats both adults and children ...
Research What rare diseases do we study at URMC? By URMC Communications Feb. 29, 2016 Rare diseases affect approximately 25 million people in the U.S., but less than 5 percent of these illnesses have a treatment. With the help of patients and their families, physicians and scientists ...
Research Aiming at Cellular ‘Neighborhood’ around Blood Cancer Improves Outcomes By URMC Communications Dec. 18, 2015 Wilmot Cancer Institute investigators have shown direct evidence of how changes in the blood-cell manufacturing environment can cause cells to malfunction and turn cancerous. The research, reported ...
Research Clinical Trial Results Show New Drug is Better for CLL Patients By Leslie Orr Dec. 6, 2015 Older adults with chronic lymphocytic leukemia may now have an alternative to toxic chemotherapy as their first treatment, according to a national study co-authored by a UR Medicine Wilmot Cancer ...
Research Wilmot Scientists Aim at a Genetically Lethal Strain of Leukemia By Leslie Orr Jul. 16, 2015 Researchers at UR Medicine’s Wilmot Cancer Institute have developed what they believe to be the first mouse model to investigate why a certain subset of acute myeloid leukemia (AML) patients responds ...
Patient Care Wilmot Cancer Institute’s Blood and Marrow Transplant Program Receives Prestigious Accreditation By Ruth Harper-Rhode May. 4, 2015 The Blood and Marrow Transplant (BMT) Program at UR Medicine’s Wilmot Cancer Institute was recognized for its high level of care and detailed quality management processes with a three-year ...
Research Hematology Event Draws Wilmot Scientists, New Data By URMC Communications Dec. 5, 2013 Several members of the lymphoma and leukemia teams at the James P. Wilmot Cancer Center are to present research at the 55th annual American Society of Hematology (ASH) meeting, Dec. 7 to 10, which is ...
